Authors: Lucore, CL Trask, RV Mishkel, GJ Rocha-Singh, KJ Shelton, ME Mikell, FL Ligon, RW

Citation: Cl. Lucore et al., Impact of abciximab and coronary stenting on outcomes and costs of percutaneous coronary interventions in a community hospital, CORON ART D, 12(2), 2001, pp. 135-142

Authors: Lam, W Gill, JB Trask, RV Mallavarapu, CT Rocha-Singh, KJ Mikell, FL Mishkel, GJ Mayer, SA Aguirre, FV Yakel, D Steen, MS Kacich, RL Shelton, ME Chaitman, BR Stocke, K Katholi, R Pianfetti, L Tatum, M McMillan, S Ligon, RW Holloway, C Cohen, DJ Staten, N Laswell, K Sullivan, P Rothert, T Page, L Brooks, M Entwistle, K Drew, D

Citation: W. Lam et al., Comparative 30-day economic and clinical outcomes of platelet glycoproteinIIb/IIIa inhibitor use during elective percutaneous coronary intervention:Prairie ReoPro Versus Integrilin Cost Evaluation (PRICE) Trial, AM HEART J, 141(3), 2001, pp. 402-409

Authors: Lucore, CL Mishkel, GJ Ligon, RW Rocha-Singh, K

Citation: Cl. Lucore et al., Economic implications of coronary stenting with adjunctive IIb/IIIa receptor antagonists in a community hospital, J INVAS CAR, 11, 1999, pp. 14C-20C

Authors: Mishkel, GJ Aguirre, FV Ligon, RW Rocha-Singh, KJ Lucore, CL

Citation: Gj. Mishkel et al., Clopidogrel as adjunctive antiplatelet therapy during coronary stenting, J AM COL C, 34(7), 1999, pp. 1884-1890